Verisign (VRSN) Given Media Impact Rating of -0.12

Media headlines about Verisign (NASDAQ:VRSN) have trended somewhat negative on Friday, according to Alpha One Sentiment Analysis. The research group, a subsidiary of Accern, rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Verisign earned a news impact score of -0.12 on Alpha One’s scale. Alpha One also gave news headlines about the information services provider an impact score of 85 out of 100, meaning that recent media coverage is very likely to have an impact on the company’s share price in the immediate future.

These are some of the headlines that may have effected AlphaOne Sentiment’s scoring:

A number of equities research analysts have recently weighed in on VRSN shares. Zacks Investment Research raised Verisign from a “hold” rating to a “buy” rating and set a $93.00 price objective for the company in a research note on Saturday, February 18th. Robert W. Baird reaffirmed a “neutral” rating and issued a $85.00 price objective on shares of Verisign in a research note on Tuesday, February 28th. Cowen and Company lifted their price objective on Verisign from $89.00 to $94.00 and gave the company a “market perform” rating in a research note on Monday, April 3rd. Finally, Citigroup Inc raised Verisign from a “sell” rating to a “neutral” rating in a research note on Wednesday, April 12th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $86.20.

Verisign (NASDAQ:VRSN) traded down 0.29% on Friday, reaching $88.45. The company had a trading volume of 917,402 shares. The stock’s 50-day moving average price is $86.75 and its 200 day moving average price is $81.70. The firm has a market capitalization of $9.05 billion, a price-to-earnings ratio of 25.86 and a beta of 1.20. Verisign has a 52-week low of $74.01 and a 52-week high of $91.99.

Verisign (NASDAQ:VRSN) last issued its earnings results on Thursday, February 9th. The information services provider reported $0.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.88 by $0.04. Verisign had a net margin of 38.58% and a negative return on equity of 36.88%. The firm had revenue of $286 million for the quarter, compared to analysts’ expectations of $282.97 million. During the same quarter last year, the company posted $0.79 earnings per share. Verisign’s revenue was up 5.0% on a year-over-year basis. On average, equities analysts anticipate that Verisign will post $3.88 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/2485823/verisign-vrsn-given-media-impact-rating-of-0-12.html.

Verisign Company Profile

VeriSign, Inc is a provider of domain name registry services and Internet security. The Company operates through Registry Services and Security Services segment. Registry Services ensure the security, stability and resiliency of Internet infrastructure and services, including the .com and .net domains, and operation of the root-zone maintainer functions for the core of the Internet’s Domain Name System (DNS).

5 Day Chart for NASDAQ:VRSN

Receive News & Ratings for Verisign Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verisign Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Blackberry Returns as Stock Surges Following WannaCry
Blackberry Returns as Stock Surges Following WannaCry
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
General Motors’ Maven Launches in New York City
General Motors’ Maven Launches in New York City
Hyundai and Kia Recall Ordered by South Korea Officials
Hyundai and Kia Recall Ordered by South Korea Officials
Spirit Airlines Cancellations Cause Chaos in Airport
Spirit Airlines Cancellations Cause Chaos in Airport


© 2006-2017 Ticker Report. Google+.